TY - JOUR
T1 - Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation
T2 - Effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors
AU - Nunes, Eric J.
AU - Randall, Patrick A.
AU - Podurgiel, Samantha
AU - Correa, Mercè
AU - Salamone, John D.
N1 - Funding Information:
We wish to dedicate this paper to the memory of our esteemed colleague and dear friend, Dr. Ann Kelley. Also, we wish to thank Evan Hart and Myles Jones for their assistance with this research. This work was supported by a grant to J.S. from the National Institute of Mental Health ( MH094966 ), and to Mercè Correa from Fundació Bancaixa/U. Jaume I. ( P1.1B2010-43 ).
PY - 2013/11
Y1 - 2013/11
N2 - Mesolimbic dopamine (DA) is a critical component of the brain circuitry regulating behavioral activation and effort-related processes. Although nucleus accumbens (NAc) DA depletions or antagonism leave aspects of appetite and primary food motivation intact, rats with impaired DA transmission reallocate their instrumental behavior away from food-reinforced tasks with high response requirements, and instead select less effortful food-seeking behaviors. Previous work showed that adenosine A2A antagonists can reverse the effects of DA D2 antagonists on effort-related choice, and that stimulation of adenosine A2A receptors produces behavioral effects that are similar to those induced by DA antagonism. The present review summarizes the literature on the role of NAc DA and adenosine in effort-related processes, and also presents original data on the effects of local stimulation of muscarinic acetylcholine receptors in NAc core. Local injections of the muscarinic agonist pilocarpine directly into NAc core produces shifts in effort-related choice behavior similar to those induced by DA antagonism or A2A receptor stimulation, decreasing lever pressing but increasing chow intake in rats responding on a concurrent fixed ratio/chow feeding choice task. In contrast, injections into a neostriatal control site dorsal to the NAc were ineffective. The actions of pilocarpine on this task were attenuated by co-administration of the muscarinic antagonist scopolamine. Thus, drugs that act on DA, adenosine A2A, and muscarinic receptors regulate effort-related choice behavior, which may have implications for the treatment of psychiatric symptoms such as psychomotor slowing, fatigue or anergia that can be observed in depression and other disorders.
AB - Mesolimbic dopamine (DA) is a critical component of the brain circuitry regulating behavioral activation and effort-related processes. Although nucleus accumbens (NAc) DA depletions or antagonism leave aspects of appetite and primary food motivation intact, rats with impaired DA transmission reallocate their instrumental behavior away from food-reinforced tasks with high response requirements, and instead select less effortful food-seeking behaviors. Previous work showed that adenosine A2A antagonists can reverse the effects of DA D2 antagonists on effort-related choice, and that stimulation of adenosine A2A receptors produces behavioral effects that are similar to those induced by DA antagonism. The present review summarizes the literature on the role of NAc DA and adenosine in effort-related processes, and also presents original data on the effects of local stimulation of muscarinic acetylcholine receptors in NAc core. Local injections of the muscarinic agonist pilocarpine directly into NAc core produces shifts in effort-related choice behavior similar to those induced by DA antagonism or A2A receptor stimulation, decreasing lever pressing but increasing chow intake in rats responding on a concurrent fixed ratio/chow feeding choice task. In contrast, injections into a neostriatal control site dorsal to the NAc were ineffective. The actions of pilocarpine on this task were attenuated by co-administration of the muscarinic antagonist scopolamine. Thus, drugs that act on DA, adenosine A2A, and muscarinic receptors regulate effort-related choice behavior, which may have implications for the treatment of psychiatric symptoms such as psychomotor slowing, fatigue or anergia that can be observed in depression and other disorders.
UR - http://www.scopus.com/inward/record.url?scp=84887989544&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84887989544&partnerID=8YFLogxK
U2 - 10.1016/j.neubiorev.2013.04.002
DO - 10.1016/j.neubiorev.2013.04.002
M3 - Review article
C2 - 23583616
AN - SCOPUS:84887989544
SN - 0149-7634
VL - 37
SP - 2015
EP - 2025
JO - Neuroscience and Biobehavioral Reviews
JF - Neuroscience and Biobehavioral Reviews
IS - 9
ER -